Shamburg News · 8-K filed Oct 29, 2026, 5:15 PM EDT
ProKidney Corp. Enters $200 Million At-the-Market Equity Sales Agreement with Jefferies
PROK · PROKIDNEY CORP.
- Material agreement
- Financing
- Materiality: medium
On October 29, 2026, ProKidney Corp. entered into an Open Market Sale Agreement with Jefferies LLC as sales agent, under which it may offer and sell Class A common stock with an aggregate offering price of up to $200,000,000. The Sales Agent is entitled to compensation of up to 3.0% of gross offering proceeds, and the company is not obligated to sell any shares. Sales are subject to the effectiveness of a Form S-3 shelf registration statement filed October 29, 2026.
Source: SEC EDGAR, Form 8-K, Items 1.01, 9.01, accession 0001193125-26-438071.
Written from the filing by Shamburg Markets. Figures are as reported by the company.